Technical Analysis for NEOS - Neos Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 1.58 2.60% 0.04
NEOS closed up 1.99 percent on Tuesday, November 19, 2019, on 61 percent of normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Flat
See historical NEOS trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 2.60%
Bullish Engulfing Bullish 2.60%
Crossed Above 20 DMA Bullish 2.60%
Calm After Storm Range Contraction 2.60%
Fell Below 20 DMA Bearish 4.64%
Calm After Storm Range Contraction 4.64%
Down 3 Days in a Row Weakness 4.64%
50 DMA Resistance Bearish 2.60%
20 DMA Support Bullish 2.60%
Calm After Storm Range Contraction 2.60%

Older signals for NEOS ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Neos Therapeutics, Inc., a pharmaceutical company, develops, manufactures, and commercializes products for the treatment of attention deficit hyperactivity disorder (ADHD) using its drug delivery technologies. Its product candidates are extended-release (XR) medications in orally disintegrating tablets or liquid suspension dosage forms. The company manufactures and markets generic Tussionex, a hydrocodone polistirex and chlorpheniramine polistirex XR liquid suspension product indicated for the relief of cough and upper respiratory symptoms associated with allergies or colds in adults and children of six years of age and older. Its product candidates include NT-0102 methylphenidate XR orally disintegrating tablet for the treatment of ADHD; NT-0202 amphetamine XR orally disintegrating tablet for the treatment of ADHD; and NT-0201 amphetamine XR liquid suspension for the treatment of ADHD. The company is headquartered in Grand Prairie, Texas.
Pharmaceutical Drugs Pharmacology Euphoriants Psychoactive Drugs Attention Deficit Hyperactivity Disorder Cough Allergies Hydrocodone Adhd Treatment Of Attention Deficit Hyperactivity Disorder Amphetamine Drug Delivery Technologies Methylphenidate Nootropics Stimulants
Is NEOS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.62
52 Week Low 1.13
Average Volume 154,128
200-Day Moving Average 1.8217
50-Day Moving Average 1.551
20-Day Moving Average 1.5355
10-Day Moving Average 1.574
Average True Range 0.0975
ADX 28.13
+DI 23.6182
-DI 14.3454
Chandelier Exit (Long, 3 ATRs ) 1.5675
Chandelier Exit (Short, 3 ATRs ) 1.6925
Upper Bollinger Band 1.6655
Lower Bollinger Band 1.4055
Percent B (%b) 0.52
BandWidth 16.932595
MACD Line 0.0111
MACD Signal Line 0.0101
MACD Histogram 0.0011
Fundamentals Value
Market Cap 43.24 Million
Num Shares 28.1 Million
EPS -4.30
Price-to-Earnings (P/E) Ratio -0.36
Price-to-Sales 18.06
Price-to-Book 10.86
PEG Ratio -0.04
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.66
Resistance 3 (R3) 1.65 1.61 1.64
Resistance 2 (R2) 1.61 1.58 1.61 1.63
Resistance 1 (R1) 1.57 1.56 1.59 1.58 1.63
Pivot Point 1.53 1.53 1.54 1.53 1.53
Support 1 (S1) 1.49 1.50 1.51 1.50 1.45
Support 2 (S2) 1.45 1.48 1.45 1.45
Support 3 (S3) 1.41 1.45 1.44
Support 4 (S4) 1.42